Insiders Buying Outlook Therapeutics And 2 Other Stocks
Although U.S. stocks closed mixed on Thursday, there were a few notable insider trades.
12 Health Care Stocks Moving In Tuesday’s Intraday Session
Gainers Ensysce Biosciences (NASDAQ:ENSC) shares moved upwards by 46.5% to $1.67 during Tuesday’s regular session. The market value…
12 Health Care Stocks Moving In Tuesday’s Pre-Market Session
Gainers Ensysce Biosciences (NASDAQ:ENSC) stock moved upwards by 28.1% to $1.46 during Tuesday’s pre-market session. The company’s market…
Expedia To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Friday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Outlook Therapeutics Clocks FY23 EPS Loss of (0.24) Vs $(0.31) YoY, Cash and Equivalents of $23.4M and Reiterated ONS-5010 Clinical and Regulatory Path Forward in the US and EU
Upcoming Anticipated Milestones
FDA response on NORSE EIGHT Special Protocol Assessment (SPA) in early February 2024;
Commencement of NORSE EIGHT expected in first calendar quarter of 2024;
MAA decision date in the
Outlook Therapeutics Submits Special Protocol Assessment To FDA For Non-Inferiority Study Of ONS-5010; NORSE EIGHT Study On Track To Commence In Q1 2024
NORSE EIGHT study on track to commence in Q1 2024Resubmission of ONS-5010 Biologics License Application (BLA) in the U.S. expected by the end of calendar year 2024ISELIN, N.J., Dec. 19, 2023 (GLOBE NEWSWIRE) -- Outlook
This Analyst Upgrades Vision Disorder-Focused Outlook Therapeutics’ Prospects After FDA Agreement Despite Investor Concerns
Thursday, Outlook Therapeutics Inc (NASDAQ: OTLK) announced it completed the requested Type A Meetings with the FDA to discuss the
Analyst Ratings for Outlook Therapeutics
Analysts have provided the following ratings for Outlook Therapeutics (NASDAQ:OTLK) within the last quarter: Bullish Somewhat Bullish Indifferent…
Cyberark Software To Rally Around 21%? Here Are 10 Top Analyst Forecasts For Friday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Crude Oil Gains Over 2%; S&P Global Raises Profit Outlook
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 200 points on Thursday.
The Dow traded up 1.51% to 33,775.43 while the NASDAQ rose 1.71% to 13,284.72. The S&P 500 also rose, gaining, 1.77% to 4,312.70.